Role of the serotonin 5-HT2A receptor in the hyperlocomotive and hyperthermic effects of (+)-3,4-methylenedioxymethamphetamine (Q40513141)

21 September 2017

Role of the serotonin 5-HT2A receptor in the hyperlocomotive and hyperthermic effects of (+)-3,4-methylenedioxymethamphetamine (English)

1 reference

21 September 2017

David V Herin

1

1 reference

21 September 2017

Shijing Liu

2

1 reference

21 September 2017

Thomas Ullrich

3

1 reference

21 September 2017

Kenner C Rice

4

1 reference

21 September 2017

Kathryn A Cunningham

5

1 reference

21 September 2017

23 October 2004

1 reference

21 September 2017

1 reference

21 September 2017

178

1 reference

21 September 2017

4

1 reference

21 September 2017

505-513

1 reference

https://scigraph.springernature.com/pub.10.1007/s00213-004-2030-4

21 September 2017

0 references

cites work

SR46349-B, a 5-HT(2A/2C) receptor antagonist, potentiates haloperidol-induced dopamine release in rat medial prefrontal cortex and nucleus accumbens

1 reference

12 December 2020

Discriminative stimulus properties of (+/-)-fenfluramine: the role of 5-HT2 receptor subtypes

1 reference

12 December 2020

Potent serotonin (5-HT)(2A) receptor antagonists completely prevent the development of hyperthermia in an animal model of the 5-HT syndrome

1 reference

12 December 2020

Psychological and physiological effects of MDMA ("Ecstasy") after pretreatment with the 5-HT(2) antagonist ketanserin in healthy humans

1 reference

12 December 2020

A role for the mesolimbic dopamine system in the psychostimulant actions of MDMA.

1 reference

12 December 2020

Effect of the R(-) and S(+) isomers of MDA and MDMA on phosphatidyl inositol turnover in cultured cells expressing 5-HT2A or 5-HT2C receptors

1 reference

12 December 2020

Effects of dopamine D1- or D2-like receptor antagonists on the hypermotive and discriminative stimulus effects of (+)-MDMA.

1 reference

12 December 2020

An in vivo binding assay to determine central alpha(1)-adrenoceptor occupancy using [(3)H]prazosin

1 reference

12 December 2020

Acute and subchronic effects of methylenedioxymethamphetamine [(+/-)MDMA] on locomotion and serotonin syndrome behavior in the rat

1 reference

12 December 2020

Pharmacological studies of the acute effects of (+)-3,4-methylenedioxymethamphetamine on locomotor activity: role of 5-HT(1B/1D) and 5-HT(2) receptors

1 reference

12 December 2020

The molecular mechanism of "ecstasy" [3,4-methylenedioxy-methamphetamine (MDMA)]: serotonin transporters are targets for MDMA-induced serotonin release

1 reference

12 December 2020

Endogenous 5‐HT, released by MDMA through serotonin transporter‐ and secretory vesicle‐dependent mechanisms, reduces hippocampal excitatory synaptic transmission by preferential activation of 5‐HT1B receptors located on CA1 pyramidal neurons

1 reference

12 December 2020

Effect of LSD on prepulse inhibition and spontaneous behavior in the rat. A pharmacological analysis and comparison between two rat strains

1 reference

12 December 2020

Multiple 5-HT receptors are involved in the effects of acute MDMA treatment: studies on locomotor activity and responding for conditioned reinforcement

1 reference

12 December 2020

Ecstasy (MDMA): a review of its possible persistent psychological effects

1 reference

12 December 2020

Role of 5-HT(2) receptors in the tryptamine-induced 5-HT syndrome in rats

1 reference

12 December 2020

The selective serotonin-2A receptor antagonist M100907 reverses behavioral deficits in dopamine transporter knockout mice.

1 reference

12 December 2020

Human pharmacology of 3,4-methylenedioxymethamphetamine ("ecstasy"): psychomotor performance and subjective effects

1 reference

12 December 2020

The effects of MDMA and other methylenedioxy-substituted phenylalkylamines on the structure of rat locomotor activity

1 reference

12 December 2020

Actions of 5-hydroxytryptamine on ventral tegmental area neurons of the rat in vitro.

1 reference

12 December 2020

Preclinical characterization of the potential of the putative atypical antipsychotic MDL 100,907 as a potent 5-HT2A antagonist with a favorable CNS safety profile

1 reference

12 December 2020

Pharmacological studies of the acute and chronic effects of (+)-3, 4-methylenedioxymethamphetamine on locomotor activity: role of 5-hydroxytryptamine(1A) and 5-hydroxytryptamine(1B/1D) receptors.

1 reference

12 December 2020

Pharmacological characterization of the effects of 3,4-methylenedioxymethamphetamine ("ecstasy") and its enantiomers on lethality, core temperature, and locomotor activity in singly housed and crowded mice

1 reference

12 December 2020

Evidence for specific involvement of 5-HT1A and 5-HT2A/C receptors in the expression of patterns of spontaneous motor activity of the rat.

1 reference

12 December 2020

Pharmacologic profile of MDMA (3,4-methylenedioxymethamphetamine) at various brain recognition sites

1 reference

12 December 2020

Effect of ambient temperature on hyperthermia and hyperkinesis induced by 3,4-methylenedioxymethamphetamine (MDMA or "ecstasy") in rats

1 reference

12 December 2020

Effects of the selective 5-HT2A receptor antagonist MDL 100,907 on MDMA-induced locomotor stimulation in rats

1 reference

12 December 2020

Clozapine reverses hyperthermia and sympathetically mediated cutaneous vasoconstriction induced by 3,4-methylenedioxymethamphetamine (ecstasy) in rabbits and rats.

1 reference

12 December 2020

Ultrastructural localization of the serotonin 2A receptor in dopaminergic neurons in the ventral tegmental area

1 reference

12 December 2020

Microinjection of cocaine into the nucleus accumbens elicits locomotor activation in the rat.

1 reference

12 December 2020

Pharmacological differentiation and characterization of 5-HT1A, 5-HT1B, and 5-HT1C binding sites in rat frontal cortex

1 reference

12 December 2020

Small changes in ambient temperature cause large changes in 3,4-methylenedioxymethamphetamine (MDMA)-induced serotonin neurotoxicity and core body temperature in the rat.

1 reference

12 December 2020

Amphetamine-type central nervous system stimulants release norepinephrine more potently than they release dopamine and serotonin

1 reference

12 December 2020

The pharmacology of the acute hyperthermic response that follows administration of 3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy') to rats

1 reference

12 December 2020

5-HT2 receptors exert a state-dependent regulation of dopaminergic function: studies with MDL 100,907 and the amphetamine analogue, 3,4-methylenedioxymethamphetamine

1 reference

12 December 2020

Evidence for possible involvement of 5-HT(2B) receptors in the cardiac valvulopathy associated with fenfluramine and other serotonergic medications

1 reference

12 December 2020

The acute effects of amphetamine derivatives on extracellular serotonin and dopamine levels in rat nucleus accumbens.

1 reference

12 December 2020

MDMA induced hyperthermia: report of a fatality and review of current therapy

1 reference

12 December 2020

Disruption of latent inhibition in the rat by the 5-HT2 agonist DOI: effects of MDL 100,907, clozapine, risperidone and haloperidol

1 reference

12 December 2020

Selectivity of action of typical and atypical anti-psychotic drugs as antagonists of the behavioral effects of 1-[2,5-dimethoxy-4-iodophenyl]-2-aminopropane (DOI).

1 reference

12 December 2020

10.1007/S00213-004-2030-4

Identifiers

DOI

1 reference

Dimensions Publication ID

21 September 2017

0 references

1 reference